Technology: Take this app: tech firms tackle opioid crisis with software - - PressFrom - US
  •   
  •   
  •   

TechnologyTake this app: tech firms tackle opioid crisis with software

09:30  19 may  2019
09:30  19 may  2019 Source:   msn.com

Opioid crisis in Philadelphia pits feds against effort to open first-in the-nation drug injection site

Opioid crisis in Philadelphia pits feds against effort to open first-in the-nation drug injection site The U.S. attorney in Philadelphia and a nonprofit are embroiled in a battle over the organization's attempt to open a supervised opioid injection site.

Here's how new technologies are tackling the opioid crisis . Groups and Pear Therapeutics have Tech investors are attacking the market and ongoing opioid crisis in multiple ways. They tell the app the strength of their cravings and use a rating system to monitor their anger, pain and loneliness.

Can tech solve a health crisis ? There have been history-making health crises before: Cholera The Ohio Opioid Abuse, Prevention and Treatment Technology Initiative is available for tech They’re also fine-tuning the touchpoints they want to address with their app and software : tech , public safety

Technology firms are taking aim at the opioid crisis and related health problems with a new class of treatments -- digital therapeutics -- delivered by smartphone.

Former CEO of drug company first to face charges in opioid crisis

Former CEO of drug company first to face charges in opioid crisis Laurence Doud III, the former CEO of Rochester Drug Co-Operative, was indicted Tuesday for narcotics conspiracy and conspiracy to defraud the Drug Enforcement Administration. He is accused of distributing tens of millions of oxycodone, fentanyl, and other opioids that Rochester's own compliance department allegedly found had no legitimate need for them. The U.S. Attorney's Office for the Southern District of New York is expected to hold a news conference regarding the charges on Tuesday afternoon. This is a developing story. Check back for updates.

Cerner and DrFirst are teaming up to tackle the opioid crisis . But a demand for innovative ways to curb the opioid crisis also opens the door for other tech developers to provide solutions.Cutting-edge tech like AI and blockchain prove useful in combatting the opioid epidemic.

Corbett describes the opioid crisis as a “wicked problem,” data science parlance for a problem that is difficult to resolve due to incomplete or He says that more data can only help everyone find solutions to the opioid crisis together. Siddiqui agrees that the potential to release and share data is massive.

These new treatments, backed by medical research and offered by prescription, are seen as potential ways to supplement, and in some cases replace, pharmaceuticals to treat addiction and an array of other mental and physical health issues.

Smartphone technology may be well-suited to behavioral therapy for addiction, depression and other disorders by making treatment more accessible and trackable by medical professionals, researchers say.

"Digital therapeutics are validated scientific treatments delivered in the form of software, which can increase access and provide an immediacy," said Yuri Maricich, head of the clinical and regulatory team at Pear Therapeutics.

Warren releases $100 billion opioid addiction plan ahead of West Virginia visit

Warren releases $100 billion opioid addiction plan ahead of West Virginia visit Sen. Elizabeth Warren's plan would give $100 billion to address the issue over 10 years.

Can tech solve a health crisis ? There have been history-making health crises before: Cholera The Ohio Opioid Abuse, Prevention and Treatment Technology Initiative is available for tech They're also fine-tuning the touchpoints they want to address with their app and software : tech , public safety

The misuse of opioids has reached crisis levels across North America. Prescription of low-dose opioids over the medium term may be a useful pain management strategy. Nearly 1 in 10 adults live with chronic pain in the United States, and the rates are higher among older adults and women.

The company has received approval in the United States for apps to treat opioid addiction and other kinds of substance abuse.

"It's the same level of rigor (as pharmaceuticals) in terms of how the products are manufactured. We've run randomized clinic trials to make sure it produces the desired outcome and that it is safe," Maricich said.

In January, Pear launched in coordination with Novartis unit Sandoz the reSET-O prescription digital therapeutic 12-week cognitive behavioral therapy to treat opioid addiction after receiving approval by the US Food and Drug Administration.

It is offered with the commonly used medication buprenorphine for adults under the care of a therapist.

The app includes a dashboard that allows medical teams to monitor a patient's progress and offer reminders and training. The patient follows on-screen prompts by answering quiz questions, reporting medication usage and reporting substance use, cravings and triggers.

Spotlight on Oklahoma for start of trial for opioid makers

Spotlight on Oklahoma for start of trial for opioid makers Oklahoma is poised to become the first state to go to trial in a lawsuit against the makers of pharmaceuticals blamed for contributing to the nation's opioid crisis. 

The opioid crisis emerged in large part from poor understanding of how to treat chronic pain. Robust research could help to improve the way pain is managed and encourage the appropriate use of opioids . Meanwhile, better use of data could help tackle inappropriate prescribing and the diversion

The misuse of opioids has reached crisis levels across North America. Every day in 2016, 116 Americans died from opioid -related drug overdoses. Many mindfulness apps are available for use on smart phones and tablets. Building confidence to cope with pain and related barriers takes planning

- Reprogramming brain rewards -

The goal of these apps is to "reprogram" the brain's rewards system once it has been distorted by addictive substances.

With these technologies, "you disrupt that behavior chain and learn new skills to make lifestyle changes to stop self-defeating patterns," said Lisa Marsch, director of the Center for Technology and Behavioral Health at Dartmouth University, which has conducted trials with Pear and other digital therapeutics firms.

Marsch said research has been ongoing on digital therapies for decades but that the growth in smartphones has made it easier to deliver such care.

"People can use it 24/7 as a clinician in their pocket," she said.

The impact on substance addiction is notable. Forty percent of patients who used the first Pear application, reSET, along with standard therapy abstained from alcohol, cocaine, marijuana and other substances over three months compared with 17.6 percent for those receiving standard therapy alone.

For reSET-O, 82.4 percent of those using the app remained in therapy -- the so-called "retention rate" -- through 12 weeks, compared with 68.4 percent for those not using the app.

Historic opioid trial against Johnson & Johnson kicks off in Oklahoma

Historic opioid trial against Johnson & Johnson kicks off in Oklahoma Other defendants including Purdue Pharmaceuticals have settled.

Discount Codes. The Guardian app . Video. Opioid crisis : doctors among 60 charged in crackdown on illegal prescriptions. The US photographer should be applauded for using her cultural capital to take on the opioid business, writes Guardian columnist Rhiannon Lucy Cosslett.

President Trump spoke with top advisers at a meeting on the opioid crisis at his golf club in BRIDGEWATER, N.J. — President Trump promised again on Tuesday to tackle the growing “It’s a tremendous problem in our country, and I hope we get it taken care of as well as it can be taken care

Shawn Ryan, a University of Cincinnati professor of medicine and president of the Brightview addiction clinic, said one advantage of digital treatments is that therapists can better track patient progress.

"The digital platforms have figured out how to deliver that treatment and track them," he said.

"There's so much more data we get by evaluating this through digital platforms."

Additionally, digital therapies can be delivered remotely in areas where medical care is scarce.

"In many parts of the country there are not enough professionals so the alternative is nothing," Ryan said.

Opioid addiction has ravaged many US communities over the past decade.

An estimated 47,000 people died in the United States from opioid overdoses in 2017, according to the Centers for Disease Control, and 1.7 million people were suffering from addiction to painkillers like OxyContin.

Investments in digital therapeutics startups nearly doubled in 2018 to some $811 million, according to the research firm CB Insights, with $191 million tallied so far in 2019.

- Digital 'snake oil' -

"We are seeing strong interest from pharmaceutical companies," said CB Insights analyst Ja Lee.

These treatments "present a novel opportunity for patients to manage chronic diseases (and) are gaining more interest as new types of treatments enter the market, a CB Insights report said.

Juniper Research meanwhile predicts the market for digital therapeutics will top $32 billion in revenues in 2024, up from an estimated $2.2 billion in 2019, with diabetes and weight loss the biggest growth segments.

Among companies in the sector, San Francisco-based Omada is using an app offering coaching for diabetes care;, and British-based SilverCloud Health offers apps for anxiety, depression and other mental health treatments.

The treatments may include online chats, patient checklists and in some cases monitoring of data from linked devices such as sensors, wearables or insulin pumps.

Holding back the market, some analysts say, is confusion over tested digital therapies and the vast number of "wellness" applications that are freely available for conditions like insomnia and anxiety.

James Madara, chief executive of the American Medical Association, warned in 2016 of the difficulties of "separating the digital snake oil from the useful" digital tools, without specifically mentioning digital therapeutics.

Read More

Oklahoma seeks to hold J&J responsible for opioid crisis as trial ends.
USA-OPIOIDS/LITIGATION-OKLAHOMA (UPDATE 1, PIX):UPDATE 1-Oklahoma seeks to hold J&J responsible for opioid crisis as trial ends

—   Share news in the SOC. Networks

Topical videos:

usr: 1
This is interesting!